
Researchers at Penn Medicine discovered that boosting levels of beta-hydroxybutyrate (BHB), a molecule produced during a ketogenic diet, enhances the effectiveness of CAR T cell therapy—a revolutionary cancer treatment. Early studies in mice and humans suggest BHB fuels CAR T cells, improving cancer-fighting abilities. A clinical trial will test this cost-effective, low-toxicity approach in patients.

Scientists have developed a wearable sticker, the Pneumorator™, that monitors breathing non-invasively, even without skin contact. This device detects subtle changes in respiratory rate with remarkable accuracy, offering early warnings for health deterioration in conditions like COVID-19 and sepsis. Low-cost and wireless, it aims to revolutionize healthcare by enabling continuous, real-time monitoring and faster medical interventions.

A multi-institutional team, including Northwestern engineers, has received $56M from ARPA-H to pioneer vision-restoring whole-eye transplants. Over six years, they'll develop VISION strategies, including optic nerve regeneration, imaging, and preservation. Northwestern's vis-OCT technology will assess donor eyes and aid transplants. This groundbreaking effort promises breakthroughs in blindness treatment and transformative solutions for vision loss.

Microplastics, classified as contaminants of emerging concern (CECs), are found in ecosystems globally, from Mount Everest to marine life, posing significant health risks, including cancer and neurological damage.

The NMC has issued guidelines to identify fake patients, as some medical colleges admit healthy individuals on specific days to deceive inspection teams during accreditation evaluations.

John Jumper, 2024 Nobel Laureate in Chemistry, revolutionized science with AlphaFold, an AI program predicting protein structures from genetic sequences. Initially a physicist, he embraced chemistry during his Ph.D. at UChicago. His work tackles protein folding, a key to understanding diseases and designing drugs. AlphaFold's breakthroughs transform biology, enabling rapid discoveries and advancing medicine and evolution studies.

Duke University researchers discovered that stimulating the vagus nerve can reduce gut inflammation in inflammatory bowel disease (IBD) by controlling a cellular process called SUMOylation. This approach, part of bioelectronic medicine, calms immune responses, alleviates symptoms and mimics drug effects. The findings offer hope for innovative, stress-targeted therapies to manage IBD's root causes, benefiting millions worldwide.

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

NEET-UG re-exam to see unprecedented security measures, says NTA chief

India, France deepen strategic partnership with focus on innovation and technology

IIM Ranchi partners with Masai to introduce product management executive program

ISRO launches Junior Research Fellowship program, applications open until July 11

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

IIM Ranchi partners with Masai to introduce product management executive program

Doctor's prescription now mandatory for all cough syrup purchases
.jpg&w=256&q=75)
Mumbai still awaits monsoon as India grapples with a 64% rainfall deficit

NEET UG 2026 re-exam: Telegram restrictions imposed to curb fake paper leak claims
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech